Sign In
Buy PFE
$27.05
+0.290 (+1.08%)
At Close: Aug 10, 2026
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
09:16am, Wednesday, 01'st Jul 2026
Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
06:46pm, Tuesday, 30'th Jun 2026
Pfizer (PFE) closed at $24.08 in the latest trading session, marking a -1.19% move from the prior day.
3 Dirt-Cheap Stocks Under $45 Built to Outperform in a Volatile Market
12:47pm, Tuesday, 30'th Jun 2026
Volatility can lower the cost of entry into businesses that throw off real cash, even as investors recognize that a low share price alone is no guarantee of a bargain. Heading into the back half of 20
Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat
12:15pm, Tuesday, 30'th Jun 2026
I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I am not slowing down.
This 7% Yielding Healthcare Powerhouse Belongs in Retirees' Portfolios
09:50am, Tuesday, 30'th Jun 2026
Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction).
Why Pfizer Could Prove to Be an Underrated GLP-1 Stock
09:00am, Tuesday, 30'th Jun 2026
It could prove to be a case of better later than never for the healthcare giant.
Merck, AbbVie probed by US lawmakers over China clinical trials: report
08:19am, Tuesday, 30'th Jun 2026
A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck...
Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.
04:43pm, Monday, 29'th Jun 2026
This relationship between inflation and value stocks' outperformance is often overlooked. Many investment experts mistakenly believe that a strong economy, not inflation, is the key to value stocks be
3 No-Brainer Dividend Stocks to Buy Right Now
11:43am, Monday, 29'th Jun 2026
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.
66 With $1.3 Million. Here Are 3 Hidden Gems to Target
10:51am, Monday, 29'th Jun 2026
At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000 a year before Social Security. The cash flow underneath these three blue chips is what matters most
3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More
05:55am, Monday, 29'th Jun 2026
Why settle for puny yields when you can buy these monster dividend stocks?
Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review
01:20am, Monday, 29'th Jun 2026
Pfizer's GLP-1 drug Ecnoglutide and Innovent Biologics' mazdutide injection have passed a preliminary review to be potentially included in China's basic medical insurance dr
A CFO Departure. A Clinical Miss.
04:30am, Sunday, 28'th Jun 2026
One of Pfizer's promising oncology candidates recently failed a phase 3 study. The drugmaker is also losing its CFO.
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
03:15pm, Saturday, 27'th Jun 2026
Pfizer is one of the world's largest drug companies. It has a long history of navigating the industry's ups and downs.
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly Dividends
11:47am, Saturday, 27'th Jun 2026
Pfizer's high yield is the result of the stock's lingering underperformance, reflecting one serious concern. To circumvent this headwind, the company has been rebuilding and continues to rebuild itsel
